MediWound (MDWD) Other Non-Current Assets (2013 - 2026)
MediWound (MDWD) posted quarterly Other Non-Current Assets of $439000.0 for Q4 2025, little changed year-over-year from $439000.0 in Q4 2024, and down 3.09% quarter-over-quarter from $453000.0 in Q2 2025.
MediWound (MDWD) Other Non-Current Assets (2013 - 2026) Analysis & Trends
MediWound's Other Non-Current Assets history runs 11 years deep, the most recent figure standing at $439000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $439000.0; the TTM figure through Dec 2025 stood at $439000.0 (changed 0.0% YoY), while the FY2025 annual figure was $439000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $439000.0, down from $453000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $453000.0 in Q2 2024, with the low at $184000.0 in Q4 2022.
- The 4-year median for Other Non-Current Assets is $439000.0 (2024), against an average of $413444.4.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 139.13% in 2023, then decreased 0.23% in 2024.
- MediWound's Other Non-Current Assets stood at $184000.0 in 2022, then surged by 139.13% to $440000.0 in 2023, then declined by 0.23% to $439000.0 in 2024, then changed by 0.0% to $439000.0 in 2025.
- Business Quant data shows MDWD's Other Non-Current Assets at $439000.0 in Q4 2025, $453000.0 in Q2 2025, and $439000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 449,000.00 |
| Dec 31, 2025 | 439,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Dec 31, 2024 | 439,000.00 |
| Sep 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 453,000.00 |
| Mar 31, 2024 | 446,000.00 |
| Dec 31, 2023 | 440,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Dec 31, 2022 | 184,000.00 |
| Dec 31, 2019 | 6,000.00 |
| Sep 30, 2019 | 14,000.00 |
| Jun 30, 2019 | 19,000.00 |
| Mar 31, 2019 | 17,000.00 |
| Dec 31, 2018 | 48,000.00 |
| Sep 30, 2018 | 57,000.00 |
| Jun 30, 2018 | 65,000.00 |
| Mar 31, 2018 | 54,000.00 |
| Dec 31, 2017 | 56,000.00 |
| Sep 30, 2017 | 60,000.00 |